Actively Recruiting
Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-05-15
90
Participants Needed
1
Research Sites
129 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is to evaluate the long-term immunogenicity of a boost dose of MVA-BN vaccine
CONDITIONS
Official Title
Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men aged over 18 years
- Have received two doses of MVA-BN vaccine as an initial schedule
- Eligible for a booster dose of MVA-BN according to HAS recommendation
- Eligible for and wish to initiate or are followed for HIV PrEP treatment
- Covered by social security (excluding AME)
You will not qualify if you...
- History of virologically confirmed mpox
- Under guardianship or curatorship
- Subject to a judicial protection measure
- Have a contraindication to mpox vaccination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CIC 1417Cochin-Pasteur
Paris, Paris, France, 75679
Actively Recruiting
Research Team
L
Liem Binh Luong Nguyen, Degree medical doctor
CONTACT
O
Odile LAUNAY, PUPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here